Ostar

Telehealth solutions firm Ostar Healthcare Technology has introduced its cellular telehealth blood pressure monitoring system in North America.

The Ostar Cellular P201 Remote TeleHealth Blood Pressure Gateway System is designed to help reduce 30 day readmission rates for heart patients, specifically for congestive heart failure (CHF).

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Ostar Healthcare Technology CEO Doug Hemenway said: “This North American launch of Ostar Cellular P201 brings forth another market first, a unique cell enabled health device with a combined data gateway approach.

“The Ostar P201 delivers more than real-time remote blood pressure monitoring.

“The Ostar Cellular P201 Remote TeleHealth Blood Pressure Gateway System is designed to help reduce 30 day readmission rates for heart patients, specifically for congestive heart failure (CHF).”

“It also provides data input gateway ability, accepting and transmitting other patient centered data from glucometers, weighing scales and all other vital signs devices.”

The P201 system features a cellular device with a combined mHealth Personal Dashboard app, which transmits relevant data to population health management systems, wellness platforms, electronic medical records (EMRs) and health information exchanges (HIEs) worldwide.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The company said the P201 Remote TeleHealth Blood Pressure Gateway System is the first in the Cellular P Series to be released.

Ostar Healthcare Technology chief operating officer Paul Markham said: “Given the current transformation of healthcare in the US, this simple cellular enabled, insurance card enabled, remote TeleHealth solution, has the potential to positively impact advanced chronic disease management outcomes.”

The company said the concept will impact shared saving plans in accountable care organisations, and positively impact health insurance indicators such as Healthcare Effectiveness Data and Information Set (HEDIS), with regards to Medicare Advantage Star Rating programmes.

Image: Ostar Healthcare’s P201 Remote TeleHealth Blood Pressure Gateway System. Photo: courtesy of PRNewswire / Ostar Healthcare Technology.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact